(Q35531092)

English

A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil

scientific article published on December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

pregnant person

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J S Lambert

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

S A Nogueira

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

T Abreu

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

E S Machado

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

T P Costa

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

M Bondarovsky

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

M Andrade

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

M Halpern

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

R Barbosa

9

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

M Perez

10

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sexually Transmitted Infections

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

448-452

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

27 July 2018

Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

27 July 2018

Initial multicenter experience with double nucleoside therapy for human immunodeficiency virus infection during pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

27 July 2018

Drugs in pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

27 July 2018

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

27 July 2018

Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Experience of nevirapine use in a London cohort of HIV-infected pregnant women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Antiretroviral therapy in pregnancy: a focus on safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

26 September 2018

Perinatal Exposure to Zidovudine — Benefits and Risks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1744786

7 December 2018

Long-term antiretroviral combination therapy including lamivudine in HIV-1 infected women during pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14663118

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/14663118

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/STI.79.6.448

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35531092&oldid=1868616298"